Marlene Gyldmark
Direktor/Vorstandsmitglied bei International Society for Pharmacoeconomics & Outcomes Rsch
Profil
Marlene Gyldmark is currently the Director at the International Society for Pharmacoeconomics & Outcomes Research.
She has a graduate degree from York University and another graduate degree from the University of Copenhagen.
Aktive Positionen von Marlene Gyldmark
| Unternehmen | Position | Beginn |
|---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
 International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Direktor/Vorstandsmitglied | - |
Ausbildung von Marlene Gyldmark
| University of Copenhagen | Graduate Degree |
| York University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |
